Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius : Nestle may sell U.S. confectionery business

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/15/2017 | 02:46pm EDT
Nestle candy products are displayed the company's news conference in New York

LONDON (Reuters) - Nestle (>> Nestlé) may sell its roughly $900 million-a-year U.S. confectionery business, which includes Butterfinger and BabyRuth, in the Swiss food group's latest effort to improve the health profile of its sprawling portfolio.

LONDON (Reuters) - Nestle (>> Nestlé) may sell its roughly $900 million-a-year U.S. confectionery business, which includes Butterfinger and BabyRuth, in the Swiss food group's latest effort to improve the health profile of its sprawling portfolio.

The world's largest packaged foods maker said on Thursday it would "explore strategic options", including a possible sale, for the business that also includes 100Grand, SkinnyCow and Raisinets.

Analysts have been speculating that Nestle could exit the U.S. confectionary business which is not in line with its stated strategy of becoming more health and nutrition-focused.

That strategy, underlined by last year's naming of a healthcare veteran as CEO, comes as the whole packaged food sector battles a slowdown from a new generation of savvy consumers that are eating fresher and healthier foods.

The review is limited to the United States, where Nestle does not control its key KitKat brand, and is No. 4 behind Mars, Hershey (>> Hershey Co) and Mondelez International (>> Mondelez International).

With annual sales of 900 million Swiss francs ($923 million), the U.S. confectionery business accounts for only 1 percent of company sales. Nestle's other products range from instant coffee to mineral water and baby food.

"This might seem small stuff, but in our view it could be a significant step by new-ish CEO Mark Schneider ... toward a more deliberate and efficient capital allocation strategy," said RBC Capital Markets analyst James Edwardes Jones in a note.

Nestle said it remained "fully committed" to growing its international confectionery business, particularly KitKat, which is made in the United States by Hershey. It said it would also keep the Nestle Toll House baking products.

Globally, Nestle's confectionery business generated sales of 8.8 billion Swiss francs ($9.02 billion) last year.

TO-DO LIST

The global packaged food industry has seen a wave of deals as companies seek to boost profits in a weak market.

Unilever (>> Unilever) is trying to sell its shrinking margarines business after rebuffing a takeover bid by Kraft Heinz (>> The Kraft Heinz Company), and Reckitt Benckiser Group (>> Reckitt Benckiser) is selling its French's mustard business to pay down debt from its purchase of Mead Johnson (>> Mead Johnson Nutrition CO), which closed on Thursday.

Nestle had organic sales growth of 3.2 percent last year, which Bernstein analysts said was the lowest of this century and the fifth straight year of slowing growth.

With that backdrop, Nestle has pushed aggressively into areas of health and nutritional science, buying and investing in a range of biotech and medical device firms, as it presses the boundaries between food and medicine.

At the same time it has divested underperforming businesses including the Nutrament drink, Jenny Craig diet business and PowerBar snacks. Last year, it formed an ice cream joint venture with Britain's R&R.

Last year, RBC's Jones said a strategic review of the confectionery business should be near the top of the new CEO's to-do list. "It's incompatible with Nestle's strategy, margins are falling and its competitive position is anemic," he said.

The clear U.S. leader is Hershey, which last year rejected a takeover offer by its more international rival, Mondelez.

(Reporting by Martinne Geller; Editing by Ben Hirschler and Edmund Blair)

By Martinne Geller

Stocks mentioned in the article
ChangeLast1st jan.
FORBO HOLDING AG -1.19% 1751 Delayed Quote.28.31%
FRESENIUS SE & CO. KGAA -0.65% 45.03 Delayed Quote.6.25%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO. KGAA
07/18CVS to Test a Device For Dialysis at Home -- WSJ
DJ
07/09Drugmakers Rise After Trump Pricing Rule Is Blocked
DJ
07/02FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by ..
EQ
07/01FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
06/27FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/21FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/14FRESENIUS : Medical Care successfully places USD bonds
PU
06/12FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
06/11FRESENIUS : Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist Pr..
AQ
More news
Financials (EUR)
Sales 2019 35 381 M
EBIT 2019 4 630 M
Net income 2019 1 883 M
Debt 2019 19 733 M
Yield 2019 1,79%
P/E ratio 2019 13,3x
P/E ratio 2020 12,5x
EV / Sales2019 1,27x
EV / Sales2020 1,17x
Capitalization 25 127 M
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 56,64  €
Last Close Price 45,13  €
Spread / Highest target 57,2%
Spread / Average Target 25,5%
Spread / Lowest Target -28,1%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors